Lung Institute in PA

Air Quality in PA

The American Lung Association recently released their 2015 State of the Air report listing the cities with the cleanest and most polluted air. Unfortunately for Pittsburgh, the city once again ranked among those with the most polluted air in the nation. With the combination of the pollution in the air, the high prevalence of lung disease in the area and the local steel mills and coal mines, many people believe that occupational lung disease in Pittsburgh is on the rise. However, help is on the way. Keep your eye out for the Lung Institute in PA in July of 2015.

What is Occupational Lung Disease?

Simplistically, occupational lung disease is a respiratory condition that develops due to polluted air in the workplace. This can include sand and dust particles, harsh chemicals, small metal particles, and in the case of black lung disease, coal dust. Most people assume that these lung diseases don’t develop unless there is some additional cause like smoking, or at the very least, that it takes years to come about. Unfortunately, this isn’t true. Around 19 percent of COPD cases are attributed to occupational lung disease and 31 percent of overall cases are found in people that never smoked. A history of exposure may be needed to develop a lung disease, but as early as the initial exposure, lung damage can occur.

Cellular Therapy

Many lung disease sufferers have opted for cellular therapy to improve their lung function. While cellular therapy isn’t a cure for lung disease, it has improved many patients’ quality of life. Everyone has cells in their bodies that act as our body’s system to promote healing. Cellular therapy specifically targets damaged areas and accelerates the healing process. The Lung Institute uses a minimally invasive procedure that extracts cells from fat tissue, blood or bone marrow, and reintroduces them back into the body, targeting the damaged lung tissue. Cellular therapy has significantly improved many patients’ lives by allowing them to breathe easier and do the things that they once enjoyed.

The Lung Institute is coming to PA

The Lung Institute has completed over 800 treatments in the past two years, and is expanding rapidly. They are looking forward to opening a new clinic in Pittsburgh in July 2015.

About the Staff

Dr. Jack Coleman, Jr., MD, will be the Medical Director of the Pittsburgh clinic. Dr. Coleman earned his medical degree from the University of Cincinnati. He later became an otolaryngology resident at the University of Pittsburgh Eye and Ear Hospital. He also served as a Lieutenant Commander and Commander in the United States Naval Reserve. Dr. Coleman is a diplomat of the National Board of Medical Examiners, is Board Certified in Otolaryngology and is a Fellow of the American Academy of Otolaryngology and Head and Neck Surgery. He is also a member of numerous medical societies including the American Medical Association, American Rhinologic Society, Association of Military Surgeons of the United States and the Pan-American Society of Otolaryngology. Along with his distinguished medical career, Dr. Coleman is a published author for several medical books and is referenced in numerous medical journals.

Although Pittsburgh has some of the highest levels of air pollution in the United States, there is hope for those suffering from COPD. The Lung Institute is on its way.

If you or a loved one suffers from chronic lung disease, contact the Lung Institute to find out if cellular therapy can help get your life back within reach. Contact us by calling (800) 729-3065 to see if you qualify.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.